- Home
- IMRN vs ADIL Comparison
IMRN vs ADIL Comparison
Compare IMRN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- ADIL
- Stock Information
- Founded
- IMRN 1994
- ADIL 2010
- Country
- IMRN Australia
- ADIL United States
- Employees
- IMRN N/A
- ADIL N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- IMRN Health Care
- ADIL Health Care
- Exchange
- IMRN Nasdaq
- ADIL Nasdaq
- Market Cap
- IMRN 9.2M
- ADIL 7.6M
- IPO Year
- IMRN N/A
- ADIL 2018
- Fundamental
- Price
- IMRN $1.92
- ADIL $0.34
- Analyst Decision
- IMRN Strong Buy
- ADIL Strong Buy
- Analyst Count
- IMRN 1
- ADIL 1
- Target Price
- IMRN $5.00
- ADIL $8.00
- AVG Volume (30 Days)
- IMRN 41.7K
- ADIL 586.6K
- Earning Date
- IMRN 08-29-2025
- ADIL 11-12-2025
- Dividend Yield
- IMRN N/A
- ADIL N/A
- EPS Growth
- IMRN N/A
- ADIL N/A
- EPS
- IMRN N/A
- ADIL N/A
- Revenue
- IMRN $4,777,422.00
- ADIL N/A
- Revenue This Year
- IMRN N/A
- ADIL N/A
- Revenue Next Year
- IMRN N/A
- ADIL N/A
- P/E Ratio
- IMRN N/A
- ADIL N/A
- Revenue Growth
- IMRN 48.63
- ADIL N/A
- 52 Week Low
- IMRN $1.50
- ADIL $0.22
- 52 Week High
- IMRN $2.87
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- IMRN 56.80
- ADIL 36.41
- Support Level
- IMRN $1.85
- ADIL $0.36
- Resistance Level
- IMRN $1.94
- ADIL $0.38
- Average True Range (ATR)
- IMRN 0.08
- ADIL 0.02
- MACD
- IMRN 0.00
- ADIL 0.00
- Stochastic Oscillator
- IMRN 86.67
- ADIL 7.75
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.